{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:45:42Z","timestamp":1740141942266,"version":"3.37.3"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT06275-FR14911"],"award-info":[{"award-number":["IT06275-FR14911"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The incidence of cancer has been increasing worldwide. Unfortunately, the drugs used in cancer chemotherapy are toxic to both neoplasms and normal tissues, while many available medications have low potencies. Conjugated \u03b1,\u03b2-unsaturated ketones differ structurally from contemporary anticancer medications, and some of which have<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>To design and synthesize highly potent cytotoxins with far greater toxicity to neoplasms than to non-malignant cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A series of N-acyl-3,5-bis(benzylidene)-4-piperidone hydrochlorides 4a-n were prepared and evaluated against Ca9-22, HSC-2, HSC-3, and HSC-4 squamous cell carcinomas as well as aginst HGF, HPLF, and HPC non-malignant cells. QSAR and western blot analyses were performed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The majority of compounds display submicromolar CC50 values towards the neoplasms; the figures for some of the compounds are below 10-7 M. In general, 4a-n have much lower CC50 values than those of melphalan, 5-fluorouracil, and methotrexate, while some compounds are equitoxic with doxorubicin.  The compounds are far less toxic to the non-malignant cells, giving rise to substantial selectivity index (SI) figures. A QSAR study revealed that both potency and the SI data were controlled to a large extent by the electronic properties of the substituents in the arylidene aryl rings. Two representative compounds 4f and 4g caused apoptosis in HSC-2 cells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The compounds in series 4 are potent cytotoxins displaying tumor-selective toxicity. In particular, 4g with an average CC50 value of 0.04 \u00b5M towards four malignant cell lines and a selectivity index of 46.3 is clearly a lead molecule that should be further evaluated.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406418666220322154110","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:00:53Z","timestamp":1648040453000},"page":"1001-1012","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)-\n4-Piperidone Hydrochloride and Related Compounds: Potent\nCytotoxins Demonstrate Greater Toxicity to Neoplasms than Non-\nMalignant Cells"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-5790","authenticated-orcid":true,"given":"Praveen K.","family":"Roayapalley","sequence":"first","affiliation":[{"name":"Drug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5,\nCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.","family":"Dimmock","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5,\nCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakagami","sequence":"additional","affiliation":[{"name":"Meikai University Research Institute of Odontology, Sakado, Saitama 350-0283, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyki","family":"Okudaira","sequence":"additional","affiliation":[{"name":"Division of Pharmacology,\nMeikai University School of Dentistry, Sakado, Saitama 350-0283, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra K.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pathology and\nLaboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan S7N 0W8, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umashankar","family":"Das","sequence":"additional","affiliation":[{"name":"Drug Discovery and Development Research Cluster, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E5,\nCanada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"WHO fact sheets. Available from:  (Accessed on February 12, 2019)."},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.bmc.2017.05.025","volume":"25","author":"Lei X.","year":"2017","unstructured":"Lei X.; Small molecule enabled chemical biology and drug discovery. Bioorg Med Chem 2017,25(11),2815-2816","journal-title":"Bioorg Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1016\/j.bmcl.2016.03.086","volume":"26","author":"Pan W.","year":"2016","unstructured":"Pan W.; Hu K.; Bai P.; Yu L.; Ma Q.; Li T.; Zhang X.; Chen C.; Peng K.; Liu W.; Sang Z.; De-sign, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2016,26(10),2539-2543","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1021\/jm5006463","volume":"57","author":"Anighoro A.","year":"2014","unstructured":"Anighoro A.; Bajorath J.; Rastelli G.; Polypharmacology: Challenges and opportunities in drug dis-covery. J Med Chem 2014,57(19),7874-7887","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1016\/j.bmc.2018.08.019","volume":"26","author":"Mart\u00ednez A.","year":"2018","unstructured":"Mart\u00ednez A.; Zahran M.; Gomez M.; Cooper C.; Guevara J.; Ekengard E.; Nordlander E.; Alcen-dor R.; Hambleton S.; Novel multi-target compounds in the quest for new chemotherapies against Alzheimer\u2019s disease: An experimental and theoretical study. Bioorg Med Chem 2018,26(17),4823-4840","journal-title":"Bioorg Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.ejmech.2017.10.021","volume":"143","author":"Raghavendra N.M.","year":"2018","unstructured":"Raghavendra N.M.; Pingili D.; Kadasi S.; Mettu A.; Prasad S.V.U.M.; Dual or multi-targeting inhib-itors: The next generation anticancer agents. Eur J Med Chem 2018,143,1277-1300","journal-title":"Eur J Med Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.2174\/1568026617666170707124126","volume":"17","author":"Zheng W.","year":"2017","unstructured":"Zheng W.; Zhao Y.; Luo Q.; Zhang Y.; Wu K.; Wang F.; Multi-targeted anticancer agents. Curr Top Med Chem 2017,17(28),3084-3098","journal-title":"Curr Top Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2174\/1568026617666171004155437","volume":"17","author":"Chen Z-F.","year":"2017","unstructured":"Chen Z-F.; Orvig C.; Liang H.; Multi-target metal-based anticancer agents. Curr Top Med Chem 2017,17(28),3131-3145","journal-title":"Curr Top Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejmech.2016.03.002","volume":"115","author":"Ng H-L.","year":"2016","unstructured":"Ng H-L.; Chen S.; Chew E-H.; Chui W.K.; Applying the designed multiple ligands approach to in-hibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity. Eur J Med Chem 2016,115,63-74","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejmech.2017.05.016","volume":"136","author":"Fu R.G.","year":"2017","unstructured":"Fu R.G.; Sun Y.; Sheng W.B.; Liao D.F.; Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. Eur J Med Chem 2017,136,195-211","journal-title":"Eur J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejmech.2017.04.025","volume":"135","author":"Zha G.F.","year":"2017","unstructured":"Zha G.F.; Qin H.L.; Youssif B.G.M.; Amjad M.W.; Raja M.A.G.; Abdelazeem A.H.; Bukhari S.N.A.; Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance. Eur J Med Chem 2017,135,34-48","journal-title":"Eur J Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.bmc.2016.11.048","volume":"25","author":"Li Y.","year":"2017","unstructured":"Li Y.; Qiang X.; Luo L.; Yang X.; Xiao G.; Zheng Y.; Cao Z.; Sang Z.; Su F.; Deng Y.; Multi-target drug design strategy against Alzheimer\u2019s disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional proper-ties. Bioorg Med Chem 2017,25(2),714-726","journal-title":"Bioorg Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ejmech.2016.07.021","volume":"123","author":"Olsen J.I.","year":"2016","unstructured":"Olsen J.I.; Plata G.B.; Padr\u00f3n J.M.; L\u00f3pez \u00d3.; Bols M.; Fern\u00e1ndez-Bola\u00f1os J.G.; Selenoureido-iminosugars: A new family of multitarget drugs. Eur J Med Chem 2016,123,155-160","journal-title":"Eur J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","volume":"138","author":"De Cesco S.","year":"2017","unstructured":"De Cesco S.; Kurian J.; Dufresne C.; Mittermaier A.K.; Moitessier N.; Covalent inhibitors design and discovery. Eur J Med Chem 2017,138,96-114","journal-title":"Eur J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1016\/j.bmc.2016.06.049","volume":"24","author":"Disney M.D.","year":"2016","unstructured":"Disney M.D.; Chemistry and chemical biology of therapeutically important compounds. Bioorg Med Chem 2016,24(17),3875","journal-title":"Bioorg Med Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/cmdc.200900499","volume":"5","author":"Amslinger S.","year":"2010","unstructured":"Amslinger S.; The tunable functionality of \u03b1,\u03b2-unsaturated carbonyl compounds enables their differ-ential application in biological systems. ChemMedChem 2010,5(3),351-356","journal-title":"ChemMedChem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bmcl.2013.10.003","volume":"24","author":"Mah R.","year":"2014","unstructured":"Mah R.; Thomas J.R.; Shafer C.M.; Drug discovery considerations in the development of covalent inhibitors. Bioorg Med Chem Lett 2014,24(1),33-39","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.1021\/acs.est.6b04981","volume":"51","author":"Slawik C.","year":"2017","unstructured":"Slawik C.; Rickmeyer C.; Brehm M.; B\u00f6hme A.; Sch\u00fc\u00fcrmann G.; Glutathione adduct patterns in Michael-acceptor carbonyls. Environ Sci Technol 2017,51(7),4018-4026","journal-title":"Environ Sci Technol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1021\/acs.jmedchem.6b01815","volume":"60","author":"Zhao Z.","year":"2017","unstructured":"Zhao Z.; Liu Q.; Bliven S.; Xie L.; Bourne P.E.; Determining cysteines available for covalent inhi-bition across the human kinome. J Med Chem 2017,60(7),2879-2889","journal-title":"J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1248\/cpb.c15-00986","volume":"64","author":"Horiyama S.","year":"2016","unstructured":"Horiyama S.; Hatai M.; Takahashi Y.; Date S.; Masujima T.; Honda C.; Ichikawa A.; Yoshikawa N.; Nakamura K.; Kunitomo M.; Takayama M.; Intracellular metabolism of alpha,beta-unsaturated carbonyl compounds, acrolein, crotonaldehyde and methyl vinyl ketone, active toxicants in cigarette smoke: Participation of glutathione conjugation ability and aldehyde-ketone sensitive reductase activi-ty. Chem Pharm Bull (Tokyo) 2016,64(6),585-593","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3109\/00498254.2012.754112","volume":"43","author":"Maydt D.","year":"2013","unstructured":"Maydt D.; De Spirt S.; Muschelknautz C.; Stahl W.; M\u00fcller T.J.J.; Chemical reactivity and biologi-cal activity of chalcones and other \u03b1,\u03b2-unsaturated carbonyl compounds. Xenobiotica 2013,43(8),711-718","journal-title":"Xenobiotica"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jps.2600720812","volume":"72","author":"Dimmock J.R.","year":"1983","unstructured":"Dimmock J.R.; Shyam K.; Hamon N.W.; Logan B.M.; Raghavan S.K.; Harwood D.J.; Smith P.J.; Evaluation of some Mannich bases derived from substituted acetophenones against P-388 lymphocyt-ic leukemia and on respiration in isolated rat liver mitochondria. J Pharm Sci 1983,72(8),887-894","journal-title":"J Pharm Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0003-2697(89)90045-6","volume":"177","author":"Mutus B.","year":"1989","unstructured":"Mutus B.; Wagner J.D.; Talpas C.J.; Dimmock J.R.; Phillips O.A.; Reid R.S.; 1-p-chlorophenyl-4,4-dimethyl-5-diethylamino-1-penten-3-one hydrobromide, a sulfhydryl-specific compound which reacts irreversibly with protein thiols but reversibly with small molecular weight thiols. Anal Biochem 1989,177(2),237-243","journal-title":"Anal Biochem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/mutage\/gei054","volume":"20","author":"Jenkins G.J.S.","year":"2005","unstructured":"Jenkins G.J.S.; Doak S.H.; Johnson G.E.; Quick E.; Waters E.M.; Parry J.M.; Do dose response thresholds exist for genotoxic alkylating agents? Mutagenesis 2005,20(6),389-398","journal-title":"Mutagenesis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.dnarep.2007.03.008","volume":"6","author":"Kaina B.","year":"2007","unstructured":"Kaina B.; Christmann M.; Naumann S.; Roos W.P.; MGMT: Key node in the battle against geno-toxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst) 2007,6(8),1079-1099","journal-title":"DNA Repair (Amst)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1089\/ars.2012.4909","volume":"19","author":"Gan F-F.","year":"2013","unstructured":"Gan F-F.; Kaminska K.K.; Yang H.; Liew C-Y.; Leow P-C.; So C-L.; Tu L.N.L.; Roy A.; Yap C-W.; Kang T-S.; Chui W-K.; Chew E-H.; Identification of Michael acceptor-centric pharmaco-phores with substituents that yield strong thioredoxin reductase inhibitory character correlated to an-tiproliferative activity. Antioxid Redox Signal 2013,19(11),1149-1165","journal-title":"Antioxid Redox Signal"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1021\/jm700988f","volume":"50","author":"Safavy A.","year":"2007","unstructured":"Safavy A.; Raisch K.P.; Mantena S.; Sanford L.L.; Sham S.W.; Krishna N.R.; Bonner J.A.; De-sign and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 2007,50(24),6284-6288","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1021\/acs.jmedchem.5b01203","volume":"59","author":"Ai Y.","year":"2016","unstructured":"Ai Y.; Zhu B.; Ren C.; Kang F.; Li J.; Huang Z.; Lai Y.; Peng S.; Ding K.; Tian J.; Zhang Y.; Discovery of new monocarbonyl-curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer. J Med Chem 2016,59(5),1747-1760","journal-title":"J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.bmcl.2017.02.016","volume":"27","author":"Panda A.K.","year":"2017","unstructured":"Panda A.K.; Das U.; Umemura N.; Sakagami H.; Kawase M.; Balzarini J.; De Clercq E.; Dim-mock S.G.; Roayapalley P.K.; Dimmock J.R.; 6-Benzylidene-2-[4-(pyridin-3-ylcarboxy) benzyli-dene]cyclohexanones: A novel cluster of tumour-selective cytotoxins. Bioorg Med Chem Lett 2017,27(7),1611-1615","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2016.12.030","volume":"796","author":"Liang B.","year":"2017","unstructured":"Liang B.; Liu Z.; Cao Y.; Zhu C.; Zuo Y.; Huang L.; Wen G.; Shang N.; Chen Y.; Yue X.; Du J.; Li B.; Zhou B.; Bu X.; MC37, a new mono-carbonyl curcumin analog, induces G2\/M cell cycle ar-rest and mitochondria-mediated apoptosis in human colorectal cancer cells. Eur J Pharmacol 2017,796,139-148","journal-title":"Eur J Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"15374","DOI":"10.3390\/molecules200815374","volume":"20","author":"Kohyama A.","year":"2015","unstructured":"Kohyama A.; Yamakoshi H.; Hongo S.; Kanoh N.; Shibata H.; Iwabuchi Y.; Structure-activity re-lationships of the antitumor C5-curcuminoid GO-Y030. Molecules 2015,20(8),15374-15391","journal-title":"Molecules"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1021\/acs.jmedchem.5b00470","volume":"58","author":"Wang R.","year":"2015","unstructured":"Wang R.; Chen C.; Zhang X.; Zhang C.; Zhong Q.; Chen G.; Zhang Q.; Zheng S.; Wang G.; Chen Q-H.; Structure-activity relationship and pharmacokinetic studies of 1,5-diheteroarylpenta-1,4-dien-3-ones: A class of promising curcumin-based anticancer agents. J Med Chem 2015,58(11),4713-4726","journal-title":"J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"8066","DOI":"10.1021\/jm200872q","volume":"54","author":"Ferrari E.","year":"2011","unstructured":"Ferrari E.; Pignedoli F.; Imbriano C.; Marverti G.; Basile V.; Venturi E.; Saladini M.; Newly syn-thesized curcumin derivatives: Crosstalk between chemico-physical properties and biological activity. J Med Chem 2011,54(23),8066-8077","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1021\/jm1004545","volume":"53","author":"Qiu X.","year":"2010","unstructured":"Qiu X.; Du Y.; Lou B.; Zuo Y.; Shao W.; Huo Y.; Huang J.; Yu Y.; Zhou B.; Du J.; Fu H.; Bu X.; Synthesis and identification of new 4-arylidene curcumin analogues as potential anticancer agents targeting nuclear factor-\u03baB signaling pathway. J Med Chem 2010,53(23),8260-8273","journal-title":"J Med Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/0006-2952(94)90420-0","volume":"47","author":"Chen G.","year":"1994","unstructured":"Chen G.; Waxman D.J.; Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells. Biochem Pharmacol 1994,47(6),1079-1087","journal-title":"Biochem Pharmacol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0360-3016(86)90254-3","volume":"12","author":"Tsutsui K.","year":"1986","unstructured":"Tsutsui K.; Komuro C.; Ono K.; Nishidai T.; Shibamoto Y.; Takahashi M.; Abe M.; Chemosensiti-zation by buthionine sulfoximine in vivo. Int J Radiat Oncol Biol Phys 1986,12(7),1183-1186","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1016\/j.bmcl.2010.09.051","volume":"20","author":"Das S.","year":"2010","unstructured":"Das S.; Das U.; Sakagami H.; Hashimoto K.; Kawase M.; Gorecki D.K.J.; Dimmock J.R.; Sequen-tial cytotoxicity: A theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids. Bioorg Med Chem Lett 2010,20(22),6464-6468","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1021\/jm000058o","volume":"43","author":"Dimmock J.R.","year":"2000","unstructured":"Dimmock J.R.; Kandepu N.M.; Nazarali A.J.; Motaganahalli N.L.; Kowalchuk T.P.; Pugazhenthi U.; Prisciak J.S.; Quail J.W.; Allen T.M.; LeClerc R.; Santos C.L.; De Clercq E.; Balzarini J.; Se-quential cytotoxicity: A theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones and related compounds. J Med Chem 2000,43(21),3933-3940","journal-title":"J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s13402-018-0397-1","volume":"41","author":"Contreras L.","year":"2018","unstructured":"Contreras L.; Calderon R.I.; Varela-Ramirez A.; Zhang H-Y.; Quan Y.; Das U.; Dimmock J.R.; Skouta R.; Aguilera R.J.; Induction of apoptosis via proteasome inhibition in leukemia\/lymphoma cells by two potent piperidones. Cell Oncol (Dordr) 2018,41(6),623-636","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1016\/j.bmcl.2017.07.018","volume":"27","author":"Addala E.","year":"2017","unstructured":"Addala E.; Rafiei H.; Das S.; Bandy B.; Das U.; Karki S.S.; Dimmock J.R.; 3,5-Bis(3-dimethylaminomethyl-4-hydroxybenzylidene)-4-piperidone and related compounds induce glutathi-one oxidation and mitochondria-mediated cell death in HCT-116 colon cancer cells. Bioorg Med Chem Lett 2017,27(16),3669-3673","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/2212697X03666160830165250","volume":"3","author":"Santiago-V\u00e1zquez Y.","year":"2016","unstructured":"Santiago-V\u00e1zquez Y.; Das U.; Varela-Ramirez A.; Baca S.T.; Ayala-Marin Y.; Lema C.; Das S.; Baryyan A.; Dimmock J.R.; Aguilera R.J.; Tumor-selective cytotoxicity of a novel pentadiene ana-logue on human leukemia\/lymphoma cells. Clin Cancer Drugs 2016,3(2),138-146","journal-title":"Clin Cancer Drugs"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.bmc.2016.03.056","volume":"24","author":"Hossain M.","year":"2016","unstructured":"Hossain M.; Das U.; Umemura N.; Sakagami H.; Balzarini J.; De Clercq E.; Kawase M.; Dim-mock J.R.; Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones. Bioorg Med Chem 2016,24(10),2206-2214","journal-title":"Bioorg Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bmcl.2016.01.005","volume":"26","author":"Das U.","year":"2016","unstructured":"Das U.; Pati H.N.; Bar\u00e1th Z.; Csonka \u00c1.; Moln\u00e1r J.; Dimmock J.R.; 1-[3-(2-Hydroxyethylsulfanyl)propanoyl]-3,5-bis(benzyli-dene)-4-piperidones: A novel cluster of P-glycoprotein dependent multidrug resistance modulators. Bioorg Med Chem Lett 2016,26(4),1319-1321","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1021\/acs.jmedchem.5b01706","volume":"59","author":"Karki S.S.","year":"2016","unstructured":"Karki S.S.; Das U.; Umemura N.; Sakagami H.; Iwamoto S.; Kawase M.; Balzarini J.; De Clercq E.; Dimmock S.G.; Dimmock J.R.; 3,5-Bis(3-alkylaminomethyl-4-hydroxybenzylidene)-4-piperidones: A novel class of potent tumor-selective cytotoxins. J Med Chem 2016,59(2),763-769","journal-title":"J Med Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13402-016-0272-x","volume":"39","author":"Robles-Escajeda E.","year":"2016","unstructured":"Robles-Escajeda E.; Das U.; Ortega N.M.; Parra K.; Francia G.; Dimmock J.R.; Varela-Ramirez A.; Aguilera R.J.; A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells. Cell Oncol (Dordr) 2016,39(3),265-277","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.3892\/ol.2016.4480","volume":"11","author":"Nunes L.M.","year":"2016","unstructured":"Nunes L.M.; Hossain M.; Varela-Ramirez A.; Das U.; Ayala-Marin Y.M.; Dimmock J.R.; Aguilera R.J.; A novel class of piperidones exhibit potent, selective and pro-apoptotic anti-leukemia properties. Oncol Lett 2016,11(6),3842-3848","journal-title":"Oncol Lett"},{"key":"ref=47","first-page":"425","volume":"15","author":"Edraki N.","year":"2016","unstructured":"Edraki N.; Das U.; Hemateenejad B.; Dimmock J.R.; Miri R.; Comparative QSAR analysis of 3,5-bis(arylidene)-4-piperidone derivatives: The development of predictive cytotoxicity models. Iran J Pharm Res 2016,15(2),425-437","journal-title":"Iran J Pharm Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1021\/jm101595p","volume":"54","author":"Das U.","year":"2011","unstructured":"Das U.; Pati H.N.; Sakagami H.; Hashimoto K.; Kawase M.; Balzarini J.; De Clercq E.; Dim-mock J.R.; 3,5-Bis(benzylidene)-1-[3-(2-hydroxyethylthio)propanoyl]piperidin-4-ones: A novel cluster of potent tumor-selective cytotoxins. J Med Chem 2011,54(9),3445-3449","journal-title":"J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejmech.2018.01.088","volume":"147","author":"Li N.","year":"2018","unstructured":"Li N.; Xin W-Y.; Yao B-R.; Wang C-H.; Cong W.; Zhao F.; Li H-J.; Hou Y.; Meng Q-G.; Hou G-G.; Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biologi-cal evaluation in vitro and in vivo. Eur J Med Chem 2018,147,21-33","journal-title":"Eur J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejmech.2018.06.027","volume":"155","author":"Li N.","year":"2018","unstructured":"Li N.; Xin W-Y.; Yao B-R.; Cong W.; Wang C-H.; Hou G-G.; N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-\u03baB inhibitors in hepatic carcinoma cell lines. Eur J Med Chem 2018,155,531-544","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.redox.2016.09.006","volume":"10","author":"Chen W.","year":"2016","unstructured":"Chen W.; Zou P.; Zhao Z.; Chen X.; Fan X.; Vinothkumar R.; Cui R.; Wu F.; Zhang Q.; Liang G.; Ji J.; Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer. Redox Biol 2016,10,78-89","journal-title":"Redox Biol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1021\/jm100589p","volume":"54","author":"Bazzaro M.","year":"2011","unstructured":"Bazzaro M.; Anchoori R.K.; Mudiam M.K.R.; Issaenko O.; Kumar S.; Karanam B.; Lin Z.; Isaks-son Vogel, R.; Gavioli, R.; Destro, F.; Ferretti, V.; Roden, R.B.S.; Khan, S.R. \u03b1,\u03b2-Unsaturated car-bonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of Human Papilloma Virus (HPV) positive cervical cancer cells. J Med Chem 2011,54(2),449-456","journal-title":"J Med Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/mc.22633","volume":"56","author":"Feng C.","year":"2017","unstructured":"Feng C.; Xia Y.; Zou P.; Shen M.; Hu J.; Ying S.; Pan J.; Liu Z.; Dai X.; Zhuge W.; Liang G.; Ruan Y.; Curcumin analog L48H37 induces apoptosis through ROS-mediated endoplasmic reticulum stress and STAT3 pathways in human lung cancer cells. Mol Carcinog 2017,56(7),1765-1777","journal-title":"Mol Carcinog"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.bmcl.2018.06.004","volume":"28","author":"Zhang W.","year":"2018","unstructured":"Zhang W.; Bai H.; Han L.; Zhang H.; Xu B.; Cui J.; Wang X.; Ge Z.; Li R.; Synthesis and bio-logical evaluation of curcumin derivatives modified with \u03b1-amino boronic acid as proteasome inhibi-tors. Bioorg Med Chem Lett 2018,28(14),2459-2464","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1016\/j.bmcl.2016.10.080","volume":"26","author":"Qiu C.","year":"2016","unstructured":"Qiu C.; Hu Y.; Wu K.; Yang K.; Wang N.; Ma Y.; Zhu H.; Zhang Y.; Zhou Y.; Chen C.; Li S.; Fu L.; Zhang X.; Liu Z.; Synthesis and biological evaluation of allylated mono-carbonyl analogues of curcumin (MACs) as anti-cancer agents for cholangiocarcinoma. Bioorg Med Chem Lett 2016,26(24),5971-5976","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejmech.2006.08.002","volume":"42","author":"Das U.","year":"2007","unstructured":"Das U.; Alcorn J.; Shrivastav A.; Sharma R.K.; De Clercq E.; Balzarini J.; Dimmock J.R.; Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds. Eur J Med Chem 2007,42(1),71-80","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejmech.2013.03.055","volume":"64","author":"Das S.","year":"2013","unstructured":"Das S.; Das U.; Michel D.; Gorecki D.K.J.; Dimmock J.R.; Novel 3,5-bis(arylidene)-4-piperidone dimers: Potent cytotoxins against colon cancer cells. Eur J Med Chem 2013,64,321-328","journal-title":"Eur J Med Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/jm0002580","volume":"44","author":"Dimmock J.R.","year":"2001","unstructured":"Dimmock J.R.; Padmanilayam M.P.; Puthucode R.N.; Nazarali A.J.; Motaganahalli N.L.; Zello G.A.; Quail J.W.; Oloo E.O.; Kraatz H-B.; Prisciak J.S.; Allen T.M.; Santos C.L.; Balzarini J.; De Clercq E.; Manavathu E.K.; A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues. J Med Chem 2001,44(4),586-593","journal-title":"J Med Chem"},{"key":"ref=59","first-page":"49","author":"Hansch C.","year":"1979","unstructured":"Hansch C.; Leo A.J.;  Substituent Constants for Correlation Analysis in Chemistry and Biology 1979,49","journal-title":"Substituent Constants for Correlation Analysis in Chemistry and Biology"},{"key":"ref=60","first-page":"84","author":"Hansch C.","year":"1979","unstructured":"Hansch C.; Leo A.J.;  Substituent Constants for Correlation Analysis in Chemistry and Biology 1979,84","journal-title":"Substituent Constants for Correlation Analysis in Chemistry and Biology"},{"key":"ref=61","first-page":"591","author":"Taft R.W.","year":"1956","unstructured":"Taft R.W.; Separation of polar, steric and resonance effects in reactivity. Steric Effects in Or-ganic Chemistry 1956,591","journal-title":"Steric Effects in Or-ganic Chemistry"},{"key":"ref=62","unstructured":"Statistical Package for Social Sciences, SPSS for windows, Release 17.0, SPSS. Chicago, 2008. Available from:"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ptr.1426","volume":"18","author":"Motohashi N.","year":"2004","unstructured":"Motohashi N.; Wakabayashi H.; Kurihara T.; Fukushima H.; Yamada T.; Kawase M.; Sohara Y.; Tani S.; Shirataki Y.; Sakagami H.; Satoh K.; Nakashima H.; Moln\u00e1r A.; Spengler G.; Gy\u00e9m\u00e1nt N.; Ugocsai K.; Moln\u00e1r J.; Biological activity of barbados cherry (acerola fruits, fruit of Malpighia emarginata DC) extracts and fractions. Phytother Res 2004,18(3),212-223","journal-title":"Phytother Res"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"Mosmann T.","year":"1983","unstructured":"Mosmann T.; Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983,65(1-2),55-63","journal-title":"J Immunol Methods"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molstruc.2009.07.016","volume":"936","author":"Lagisetly P.","year":"2009","unstructured":"Lagisetly P.; Powell D.R.; Awasthi V.; Synthesis and structural determination of 3,5-bis(2-fluorobenzylidene)-4-piperidone analogs of curcumin. J Mol Struct 2009,936,23-28","journal-title":"J Mol Struct"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1021\/jm9806695","volume":"42","author":"Dimmock J.R.","year":"1999","unstructured":"Dimmock J.R.; Kandepu N.M.; Nazarali A.J.; Kowalchuk T.P.; Motaganahalli N.; Quail J.W.; Mykytiuk P.A.; Audette G.F.; Prasad L.; Perj\u00e9si P.; Allen T.M.; Santos C.L.; Szydlowski J.; De Clercq E.; Balzarini J.; Conformational and quantitative structure-activity relationship study of cyto-toxic 2-arylidenebenzo-cycloalkanones. J Med Chem 1999,42(8),1358-1366","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0040-4020(01)97605-7","volume":"20","author":"Hassner A.","year":"1964","unstructured":"Hassner A.; Mead T.C.; The stereochemistry of 2-benzalcyclohexanones and 2-benzalcyclopentanones. Tetrahedron 1964,20,2201-2210","journal-title":"Tetrahedron"},{"key":"ref=68","first-page":"183","volume":"6","author":"Dimmock J.R.","year":"1990","unstructured":"Dimmock J.R.; Arora V.K.; Wonko S.L.; Hamon N.W.; Quail J.W.; Jia Z.; Warrington R.C.; Fang W.D.; Lee J.S.; 3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells. Drug Des Deliv 1990,6(3),183-194","journal-title":"Drug Des Deliv"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/chin.199544147","volume":"50","author":"Dimmock J.R.","year":"1995","unstructured":"Dimmock J.R.; Kumar P.; Chen M.; Quail J.W.; Yang J.; Allen T.M.; Kao G.Y.; Synthesis and cytotoxic evaluation of mesna adducts of some 1-aryl-4,4-dimethyl-5-(1-piperidino)-1-penten-3-one hydrochlorides. Pharmazie 1995,50(7),449-453","journal-title":"Pharmazie"},{"key":"ref=70","first-page":"248","volume":"18","author":"Dimmock J.R.","year":"1983","unstructured":"Dimmock J.R.; Raghavan S.K.; Logan B.M.; Bigam G.E.; Antileukemic evaluation of some Man-nich bases derived from 2-arylidene-1,3-diketones. Eur J Med Chem 1983,18,248-254","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0223-5234(89)90002-0","volume":"24","author":"Dimmock J.R.","year":"1989","unstructured":"Dimmock J.R.; Phillips O.A.; Wonko S.L.; Hickie R.A.; Tuer R.G.; Ambrose S.J.; Reid R.S.; Mu-tus B.; Talpas C.L.; Evaluation of some Mannich bases of conjugated styryl ketones and related com-pounds versus the WiDr colon cancer in vitro. Eur J Med Chem 1989,24,217-226","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","volume":"29","author":"Lu Y.","year":"2012","unstructured":"Lu Y.; Chen J.; Xiao M.; Li W.; Miller D.D.; An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 2012,29(11),2943-2971","journal-title":"Pharm Res"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017,7,42717","journal-title":"Sci Rep"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational ap-proaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"Veber D.F.","year":"2002","unstructured":"Veber D.F.; Johnson S.R.; Cheng H-Y.; Smith B.R.; Ward K.W.; Kopple K.D.; Molecular proper-ties that influence the oral bioavailability of drug candidates. J Med Chem 2002,45(12),2615-2623","journal-title":"J Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220322154110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202525\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220322154110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:14:58Z","timestamp":1693160098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202525\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220322154110","relation":{},"ISSN":["1573-4064"],"issn-type":[{"type":"print","value":"1573-4064"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}